Cargando…
RisksAssociated with Vortioxetine in the Established Therapeutic Indication
BACKGROUND: Vortioxetine is approved for the treatment of Major Depressive Disorder (MDD). However, the safety of this drug in a large group of populations is still unclear. Thus, we have tried to analyze the risk profile of vortioxetine. MATERIAL AND METHODS: The data related to the risk profile of...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573751/ https://www.ncbi.nlm.nih.gov/pubmed/32811416 http://dx.doi.org/10.2174/1570159X18666200818195720 |